Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma

Overview of attention for article published in Cancers, August 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 44 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,037 followers.

RT @TarakChouari: Check out our latest review on immunotherapeutics in pancreatic cancer, an update on recent advances in novel therapies a…

Check out our latest review on immunotherapeutics in pancreatic cancer, an update on recent advances in novel therapies and the challenges ahead in the pursuit of patient tailored therapies in PDAC 💉🤯💥 @Adam_Frampton1 @MDPIOpenAccess https://t.co/p…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.